Fraud - G2 Intelligence

Labs in Court Weekly Roundup

by Rachel Muenz | Mar 22, 2022 | Articles, News, Open Content

Enforcement actions involving health care fraud were again dominant over the past two weeks, based on information from the U.S. Department of Justice (DOJ) and state agencies. Of the key court cases involving the lab and/or health care industry from March 10-21, only...

New Federal Prosecutor to Target COVID-19 Fraud

by Glenn S. Demby | Mar 14, 2022 | Articles, DOJ-nir, Essential, National Lab Reporter

...

This content is for Paid Members only.
Register

Already a member? Log in here

Regulatory Roundup: New laws, regulations, cases, and enforcement actions affecting labs and the lab industry

by Glenn S. Demby | Mar 14, 2022 | Articles, Essential, National Lab Reporter, News-nir

...

This content is for Paid Members only.
Register

Already a member? Log in here

New Special Prosecutor to Crack Down on COVID-19 Relief Fraud

by Glenn S. Demby | Mar 10, 2022 | Articles, News, Open Content

Weeks after the COVID-19 public health emergency was declared, Congress passed a pair of massive bills—the Families First Coronavirus Response Act (FFCRA) and Coronavirus Aid, Relief, and Economic Security Act (CARES)—providing trillions of dollars in relief for...

Labs in Court Weekly Roundup

by Rachel Muenz | Mar 8, 2022 | Articles, News, Open Content

Court cases involving the lab and health care industries from this past week and a half have centered mostly on fraud. In addition to those cases, a former doctor was charged for unlawfully distributing opioid pills and the U.S. Department of Justice (DOJ) and...

Labs in Court Weekly Roundup

New Federal Prosecutor to Target COVID-19 Fraud

Regulatory Roundup: New laws, regulations, cases, and enforcement actions affecting labs and the lab industry

New Special Prosecutor to Crack Down on COVID-19 Relief Fraud

Labs in Court Weekly Roundup

Log In